


Healthcare Industry News: Levia
News Release - August 12, 2010
Medtronic Completes Acquisition of ATS Medical
MINNEAPOLIS--(Healthcare Sales & Marketing Network)--Medtronic, Inc. (NYSE: MDT ) today announced it has completed its acquisition of ATS Medical, Inc. following payment of $4.00 per share in cash for each share of ATS Medical stock and assumption of net debt, with a total transaction value of approximately $370 million.“Medtronic is focused on providing innovative solutions for cardiac surgeons and their patients worldwide,” said John Liddicoat, M.D., vice president and general manager of the Structural Heart business at Medtronic. “Our completed purchase of ATS Medical immediately expands Medtronic’s product offerings and pipeline of surgical valves, repair products and surgical ablation technologies.”
Medtronic is committed to advancing the treatment of structural heart disease through collaboration with leading clinicians, researchers and scientists worldwide.
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alLeviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
Related News Items
Medtronic Announces FDA Clearance for LigaSure(TM) RAS Maryland Instrument on the Hugo(TM) RAS SystemMedtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens
Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System
